Hosted on MSN1mon
10x Genomics sees robust growth across platforms in Q4 2023
10x Genomics delivered strong Q4 2023 results with substantial contributions from Xenium and Visium platforms. As the company enters 2024, its focus on expanding product adoption while managing ...
WKRN-TV1mon
10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis
Xenium RNA+Protein Multiomics: 10x Genomics shared plans to enable simultaneous detection of RNA and proteins on the same slide and tissue section to unlock multiomic insights into cellular ...
Investing1mon
10x Genomics' SWOT analysis: genomics firm faces NIH funding headwinds
10x Genomics specializes in developing and manufacturing genomics analysis technologies, with a focus on single-cell and spatial genomics. The company's product portfolio includes the Chromium and ...
Seeking Alpha1d
TXG 10x Genomics, Inc.
10x Genomics, Inc., a life science technology ... analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular ...
Stockhouse1mon
10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis
Xenium RNA+Protein Multiomics: 10x Genomics shared plans to enable simultaneous detection of RNA and proteins on the same slide and tissue section to unlock multiomic insights into cellular function ...
Investing1mon
10x Genomics' SWOT analysis: genomics firm faces NIH funding headwinds
This directly impacts the sales of 10x Genomics' high-value products, such as the Xenium platform. The company may face longer sales cycles, increased price sensitivity from customers, and ...